Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2018-01-01
2018-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Flaxseed Supplementation Improve Glycemic Control in Individuals With Pre-diabetes?
NCT01698112
The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus
NCT00363233
Flaxseed Supplementation in Prediabetic Adults (LINAPRED)
NCT05245825
The Effect of Alpha Linolenic Acid Intake on Patients With Elevated Glycemic Status
NCT05053347
Effect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in Mexico
NCT06683235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hesperidin and flaxseed
hesperidin and flaxseed
2 capsuls hesperidin and 30 g flaxseed
control
control
no supplementation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hesperidin and flaxseed
2 capsuls hesperidin and 30 g flaxseed
control
no supplementation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* A history of Cardiovascular disease, Pulmonary disease, Renal disease \& Celiac disease; Cirrhosis
* Following program to lose weight in recent 3 mo
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Nutrition and Food Technology Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Azita Hekmatdoost
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Nutrition and Food Technology Research Institute
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Yari Z, Naser-Nakhaee Z, Karimi-Shahrbabak E, Cheraghpour M, Hedayati M, Mohaghegh SM, Ommi S, Hekmatdoost A. Combination therapy of flaxseed and hesperidin enhances the effectiveness of lifestyle modification in cardiovascular risk control in prediabetes: a randomized controlled trial. Diabetol Metab Syndr. 2021 Jan 6;13(1):3. doi: 10.1186/s13098-020-00619-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6781
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.